Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of often chemically unrelated
compounds with some common therapeutic actions and side effects. They have potent anti …

Gastrointestinal cancer (GIC) is a common malignant tumour of the digestive system that
seriously threatens human health. Due to the unique organ structure of the gastrointestinal …

Statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors–HMG-CoA reductase
inhibitors) have been approved for the treatment of lipid disorders. Recently, in vivo studies …

Background: The relationship between the use of non-steroidal anti-inflammatory drugs
(NSAIDs), including aspirin, and the risk of gastric cancer has not been well studied. We …

Although endoscopic surveillance of patients with Barrett's oesophagus has been widely
implemented, its effectiveness is debateable. The recently reported low annual oesophageal …

Background Somatic genetic CDKN2A, TP53, and DNA content abnormalities are common
in many human cancers and their precursors, including esophageal adenocarcinoma (EA) …

BACKGROUND & AIMS: Regular use of aspirin and other nonsteroidal anti-inflammatory
drugs (NSAIDs) has been reported to reduce risks of esophageal adenocarcinoma (EAC) …

Conventional chemotherapeutic drugs used for the treatment of cancer patients in advanced
stages have yielded only limited benefit, regarding survival time not to mention cure of the …

It is widely accepted that non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin,
reduce the risk of cancer. The anti-cancer and anti-inflammatory effects of NSAIDs are …

Background Aspirin and other non-steroidal anti-inflammatory drugs (NSAID) probably
decrease the risk of colorectal neoplasia; however their effect on development of …